Clinical Trials
3
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Vaccine Therapy in Treating Patients With Malignant Melanoma
- Conditions
- Melanoma (Skin)
- First Posted Date
- 2005-08-10
- Last Posted Date
- 2013-12-19
- Lead Sponsor
- CancerVax Corporation
- Registration Number
- NCT00128583
- Locations
- 🇺🇸
Comprehensive Cancer Center at Desert Regional Medical Center, Palm Springs, California, United States
🇺🇸John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, California, United States
🇺🇸Lakeland Regional Cancer Center at Lakeland Regional Medical Center, Lakeland, Florida, United States
Vaccine Therapy for Patients With Stage III Melanoma
- Conditions
- Malignant Melanoma
- First Posted Date
- 2003-01-24
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- CancerVax Corporation
- Target Recruit Count
- 1118
- Registration Number
- NCT00052130
- Locations
- 🇺🇸
Arizona Cancer Center, Tucson, Arizona, United States
🇺🇸Central Arkansas Veterans Healthcare System, Little Rock, Arkansas, United States
🇺🇸University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
Vaccine Therapy for Patients With Stage IV Melanoma
- Conditions
- Malignant Melanoma
- First Posted Date
- 2003-01-24
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- CancerVax Corporation
- Target Recruit Count
- 670
- Registration Number
- NCT00052156
- Locations
- 🇺🇸
Arizona Cancer Center, Tucson, Arizona, United States
🇺🇸Central Arkansas Veterans Healthcare System, Little Rock, Arkansas, United States
🇺🇸University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States